Favrille, Bayer deal

BAY’s Berlex Laboratories Inc. subsidiary and FVRL partnered to use FVRL’s FavId in combination with Berlex’s Leukine sargramostim to treat B cell non-Hodgkin’s lymphoma (NHL). Each company received...